pyridine-3-ylglyoxal | 63464-84-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: pyridine-3-ylglyoxal
• 英文别名: oxo-pyridin-3-yl-acetaldehyde；(3-pyridyl)glyoxal；3-pyridylglyoxal；3-Pyridyl-glyoxylaldehyd；3-Pyridineacetaldehyde, alpha-oxo-；2-oxo-2-pyridin-3-ylacetaldehyde
• CAS: 63464-84-6
• 化学式: C₇H₅NO₂
• 分子量: 135.122
• InChiKey: WWWQVIHKOJBDHJ-UHFFFAOYSA-N

物化性质

• 沸点：
  230.1±22.0 °C(Predicted)
• 密度：
  1.211±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  47
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  pyridine-3-ylglyoxal 在 碘 、 二甲基亚砜 作用下， 反应 0.08h， 以91%的产率得到烟酸
  参考文献：
  名称：

  DMSO/I₂ mediated C–C bond cleavage of α-ketoaldehydes followed by C–O bond formation: a metal-free approach for one-pot esterification

  摘要：

  一锅法I₂/DMSO介导的无金属C-C键断裂反应，将芳基/杂环基或脂肪族α-酮醛转化为羧酸，随后进行酯化反应。

  DOI：

  10.1039/c5ob01015b
• 作为产物：
  描述：

  3-乙酰基吡啶 在 氢溴酸 、 二甲基亚砜 作用下， 以 水 为溶剂， 生成 pyridine-3-ylglyoxal
  参考文献：
  名称：

  通过级联过程合成 2-芳酰基-(4 或 5)-芳基-1H-咪唑和 2-羟基-3,6-二芳基吡嗪

  摘要：

  研究了由芳基甲基酮通过 DMSO-HBr 氧化和 Debus 反应的级联过程合成 (4 或 5)-芳基-2-芳酰基-1H-咪唑和 2-羟基-3,6-二芳基吡嗪。由于起始原料简单、条件温和、操作方便、咪唑和吡嗪衍生物的生物活性高，该方案在药物化学中具有很大的潜力。

  DOI：

  10.3998/ark.5550190.p008.270

文献信息

• [EN] 1,2,4-TRIAZINE-4-AMINE DERIVATIVES<br/>[FR] DÉRIVÉS DE 1,2,4-TRIAZINE-4-AMINE
  申请人：HEPTARES THERAPEUTICS LTD

  公开号：WO2011095625A1

  公开（公告）日：2011-08-11

  According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A1- A2b or, particularly, the A2a receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy1 or HetA; Cy1 represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy1 group is optionally substituted by one or more R4a substituents; HetA represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy2 or HetB; Cy2 represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, which Cy2 group is optionally substituted by one or more R4c substituents; HetB represents a 3- to 10-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one or two rings and which HetB group is optionally substituted by one or more R4d substituents.

  根据该发明提供了一种A1式化合物，可能对通过抑制A1-A2b或特别是A2a受体而得到改善的疾病或紊乱治疗有用，其中A1式化合物具有以下结构，其中，A代表Cy1或HetA；Cy1代表一个由一个、两个或三个环组成的5-至14-成员芳香、完全饱和或部分不饱和的碳环系统，该Cy1基团可选择地被一个或多个R4a取代基所取代；HetA代表一个由一个、两个或三个环组成的5-至14-成员杂环基团，可能是芳香、完全饱和或部分不饱和的，并且含有从O、S和N中选择的一个或多个杂原子，该杂环基团可能包括一个、两个或三个环，且该HetA基团可选择地被一个或多个R4b取代基所取代；B代表Cy2或HetB；Cy2代表一个由一个或两个环组成的3-至10-成员芳香、完全饱和或部分不饱和的碳环系统，该Cy2基团可选择地被一个或多个R4c取代基所取代；HetB代表一个由一个或两个环组成的3-至10-成员杂环基团，可能是芳香、完全饱和或部分不饱和的，并且含有从O、S和N中选择的一个或多个杂原子，该杂环基团可能包括一个或两个环，且该HetB基团可选择地被一个或多个R4d取代基所取代。
• Visible-light assisted one-pot preparation of aryl glyoxals from acetoarylones via in-situ arylacyl bromides formation: Selenium-free approach to acetoarylones oxidation
  作者：Palani Natarajan、Manjeet、Naveen Kumar、Sapna Devi、Kalyani Mer

  DOI：10.1016/j.tetlet.2017.01.013

  日期：2017.2

  A novel visible-light (blue LEDs: hν = 425 ± 15 nm) photocatalyzed one-pot method for the synthesis of electronically diverse aryl glyoxals in good to excellent yields from acetoarylones and green regents such as air, vitamin C and dioxane dibromide has been described. In addition, an application of the current methodology has been demonstrated for the oxidation of monoamine oxidase-B inhibitors, i

  一种新型的可见光（蓝色LED：hν  = 425±15 nm）光催化一锅法，可以从乙酰芳酮和绿色试剂（如空气，维生素C和二恶烷二溴化物）合成电子多样的芳基乙二醛，收率良好至优异。描述。另外，已经证明了当前方法的应用可用于氧化单胺氧化酶-B抑制剂，即1-（4-（（4-氟苄基）氧基）苯基）乙酮和1-（3-（（4-氯苄基）氧基）苯基）乙酮 该发现可以作为使用二氧化硒进行的传统乙酰芳酮氧化反应的有价值的替代物，二氧化硒是已知的同时氧化烯丙基，苄基，CH 3等的有害且非选择性的试剂。
• Amine derivative compounds
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20030078426A1

  公开（公告）日：2003-04-24

  An amine compound of the formula (I): 1 wherein R 1 represents an optionally substituted carbamoyl group, etc., R 2 represents a hydrogen atom, etc., R 3 represents a C 1 -C 10 alkyl group etc., W 1 , W 2 and W 3 are the same or different and each represent a single bond or a C 1 -C 8 alkylene group, X, Y and Q represent a sulfur atom, etc., Z represents a ═CH— group, etc., Ar represents a benzene ring, etc. and L represents a hydrogen atom, etc., or a pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc.

  化合物的结构式（I）如下：其中R1代表可选择取代的氨基甲酰基团，R2代表氢原子等，R3代表C1-C10烷基等，W1、W2和W3相同或不同，每个代表单键或C1-C8烷基链，X、Y和Q代表硫原子等，Z代表═CH—基团等，Ar代表苯环等，L代表氢原子等，或其药理学上可接受的盐。这些化合物在治疗和/或预防糖尿病、高脂血症、动脉硬化、癌症等疾病方面具有用处。
• Production methods of imidazole compound and salt thereof and intermediates therefor
  申请人：Sumika Fine Chemicals Co., Ltd.

  公开号：US06649768B1

  公开（公告）日：2003-11-18

  A production method including a step for converting a halogen compound of the formula (6) or a salt thereof to a glyoxal compound of the formula (2) or a salt thereof in dimethyl sulfoxide, and a step for reacting the glyoxal compound of the formula (2) or a salt thereof obtained in the previous step with ammonia and an aldehyde compound of the formula (3) or a salt thereof can conveniently produce an imidazole compound of the formula (1) or a salt thereof. The imidazole compound is a synthetic intermediate for a compound useful as pharmaceutical agents and agricultural chemicals. The production method is suitable for industrial scale production. is wherein each symbol is as defined in the specification.

  一种生产方法，包括将式（6）的卤素化合物或其盐在二甲基亚砜中转化为式（2）的甘醛化合物或其盐的步骤，以及将在前一步骤中获得的式（2）的甘醛化合物或其盐与氨和式（3）的醛化合物或其盐反应的步骤，可以方便地生产式（1）的咪唑化合物或其盐。该咪唑化合物是一种作为药物和农业化学品有用的化合物的合成中间体。该生产方法适用于工业规模生产。其中每个符号如规范中所定义。
• 1,2,4-TRIAZINE-4-AMINE DERIVATIVES
  申请人：Congreve Miles Stuart

  公开号：US20130029963A1

  公开（公告）日：2013-01-31

  According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A 1 -A 2b or, particularly, the A 2a receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy 1 or Het A ; Cy 1 represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy 1 group is optionally substituted by one or more R 4a substituents; Het A represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy 2 or Het B ; Cy 2 represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, which Cy 2 group is optionally substituted by one or more R 4c substituents; Het B represents a 3- to 10-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one or two rings and which Het B group is optionally substituted by one or more R 4d substituents.

  根据本发明提供了一种A1式化合物，该化合物可能有用于治疗通过抑制A1-A2bor，特别是A2a受体而改善的疾病或疾病状态，其中A1式化合物具有以下结构，其中A代表Cy1或HetA；Cy1代表一个5到14个成员的芳香族、完全饱和或部分不饱和的碳环状环系，包括一个、两个或三个环，该Cy1基团可以被一个或多个R4a取代；HetA代表一个5到14个成员的杂环基团，可能是芳香族、完全饱和或部分不饱和的，并且其中包含一个或多个从O、S和N中选择的杂原子，该杂环基团可以包括一个、两个或三个环，该HetA基团可以被一个或多个R4b取代；B代表Cy2或HetB；Cy2代表一个3到10个成员的芳香族、完全饱和或部分不饱和的碳环状环系，包括一个或两个环，该Cy2基团可以被一个或多个R4c取代；HetB代表一个3到10个成员的杂环基团，可能是芳香族、完全饱和或部分不饱和的，并且其中包含一个或多个从O、S和N中选择的杂原子，该杂环基团可以包括一个或两个环，该HetB基团可以被一个或多个R4d取代。